Fig. 3

Evaluation of prognostic signature efficiency. A KM curves showing a significant difference in survival between the two groups of patients. B Survival curve and survival status plot of ccRCC patients. 1, 3, and 5 years prognostic ROC curves of the training set (C) and validation set (D). ROC curves of risk score and clinical parameters in the training set (E) and validation set (F)